Skip to main content
Fig. 2 | BMC Medicine

Fig. 2

From: Construction of a risk stratification model integrating ctDNA to predict response and survival in neoadjuvant-treated breast cancer

Fig. 2

The landscape of clinical and mutational characteristics. A The landscape of highly mutated genes. B Significantly different SNV included in the model in different chemotherapy responses. C Significantly different CNV included in the model in different chemotherapy responses. D Comparing the differences in clinical characteristics of different chemotherapy responses. P values were calculated using Fisher’s exact test. The size of the white dots in B and C represents the size of the samples

Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us